RPRD Diagnostics
Carter Cliff is Founder & CEO of Vascugen, a company committed to developing treatments for patients suffering from incurable diseases including the leading cause of limb amputation. Previously he co-founded Opsis Therapeutics with the goal to reverse blinding disorders of the retina, which led to a Strategic R&D Alliance with BlueRock Therapeutics. A serial entrepreneur, Carter co-founded RPRD Diagnostics to market ethnicity-inclusive precision medicine.
This person is not in the org chart
This person is not in any offices
RPRD Diagnostics
RPRD (Right Patient Right Drug) Diagnostics specializes in providing innovative pharmacogenomics solutions, including diagnostic, analysis and supporting services to clinicians, researchers and drug developers. With decades of experience in pharmacogenomics research, clinical practice, and healthcare program development, RPRD’s team of experts strives to improve patient lives using pharmacogenomics to enable precision medicine.